Comparator TIV

Phase 3Biologic

Novartis

Comparator TIV is one of 42 biologic programs targeting Chickenpox. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ChickenpoxActive, not recruiting

InfluenzaActive, not recruiting

ChickenpoxPhase 3

Active, not recruiting

InfluenzaPhase 3

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

Fluzone

Sanofi

Preclinical

16 2

Comparator TIV

Novartis

Phase 3

3 3

Fluzone

GSK

Preclinical

37 4

Crestor

AstraZeneca

Preclinical

1 5

Avigan

AAppili Therapeutics Inc.

Preclinical

6 6

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

30 7

COMIRNATY

Pfizer

Preclinical

1 8

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 9

Focetria

CChiltern Pesquisa Clinica Ltda

Preclinical

1 10

Influenza A/H5N1

NNational Institute of Allergy and Infectious Diseases (NIAID)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Influenza3 trials

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Completed· Novartis logo

Novartis·Phase 3·NCT00464672·1,893 enrolled

Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old

Completed· Novartis logo

Novartis·Phase 3·NCT00617851·1,507 enrolled

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

Completed·NNovavax·Phase 2·NCT02307851·400 enrolled

Immunogenicity1 trial

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Completed· Novartis logo

Novartis·Phase 3·NCT01209780·3,116 enrolled

Chickenpox1 trial

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

Completed· Merck & Co. logo

Merck & Co.·Phase 3·NCT00231816·763 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Comparator TIV. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Comparator TIV compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Comparator TIV. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Novartis company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 3[1]
Company: Novartis

Comparator TIV

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Influenza3 trials

Immunogenicity1 trial

Chickenpox1 trial

References

Drug Info

Quick Facts

Related News